EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advances in the Understanding of REM Sleep Behavior Disorder as a Biomarker for Neurodegenerative Diseases

Sikawat Thanaviratananich, Andrea Nguyen, Matthew Chaung, Jeffrey S Patterson, Joyce K Lee-Iannotti

Current Sleep Medicine Reports · 25.04.2026 · 12 (1)

DOI: 10.1007/s40675-026-00364-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Sleep Medicine Reports, online erschienen am 25.04.2026. Verfasst von Sikawat Thanaviratananich und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

REM sleep behavior disorder (RBD) is a well-established prodromal marker of α-synucleinopathies, including Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Over 80% of individuals with isolated RBD (iRBD) eventually phenoconvert to a neurodegenerative disease, making it a valuable target for early diagnosis and intervention. This review highlights advances in the epidemiology, pathophysiology, and clinical features of RBD, and synthesizes evidence from longitudinal studies linking iRBD to phenoconversion risk. Emerging biomarkers—including neurophysiologic, neuroimaging, fluid, tissue, autonomic, cognitive, and genetic markers —enhance risk stratification, track disease progression and provide insight into disease mechanisms. Neuroanatomical and molecular insights support RBD as an early manifestation of synuclein pathology. With growing global research networks and a long prodromal window, iRBD represents an ideal population for neuroprotective trials. Standardization of diagnostic criteria and integration of multimodal biomarkers will be essential to advancing early detection and disease-modifying strategies in α-synucleinopathies.

Zitieren

APA

Thanaviratananich, S., Nguyen, A., Chaung, M., Patterson, J. S., & Lee-Iannotti, J. K. (2026). Advances in the Understanding of REM Sleep Behavior Disorder as a Biomarker for Neurodegenerative Diseases. Current Sleep Medicine Reports, 12(1). https://doi.org/10.1007/s40675-026-00364-0

Vancouver

Thanaviratananich S, Nguyen A, Chaung M, Patterson JS, Lee-Iannotti JK. Advances in the Understanding of REM Sleep Behavior Disorder as a Biomarker for Neurodegenerative Diseases. Current Sleep Medicine Reports. 2026;12(1). doi:10.1007/s40675-026-00364-0

BibTeX
@article{Thanaviratananich2026,
  author = {Thanaviratananich, Sikawat and Nguyen, Andrea and Chaung, Matthew and Patterson, Jeffrey S and Lee-Iannotti, Joyce K},
  title = {Advances in the Understanding of REM Sleep Behavior Disorder as a Biomarker for Neurodegenerative Diseases},
  journal = {Current Sleep Medicine Reports},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1007/s40675-026-00364-0}
}
Kostenlos starten →